U.S. Markets closed

Is This Rare Berkshire Hathaway Miscue Finally a Buy?

·4 min read
Is This Rare Berkshire Hathaway Miscue Finally a Buy?

Berkshire Hathaway cut bait with the struggling drugmaker Teva Pharmaceutical Industries in late 2021.